Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Alzheimer's Disease

Free Subscription Articles published in J Neurol Neurosurg Psychiatry Retrieve available abstracts of 35 articles: HTML format

Single Articles

September 2025
1. LEE M, Lee KJ, Kim J, Lee DY, et al
   Low-density lipoprotein cholesterol levels and risk of incident dementia: a distributed network analysis using common data models.
   J Neurol Neurosurg Psychiatry. 2025;96:981-989.
   PubMed     Abstract available
   
   
   
2. ZHAO Y, Fei L
   Smoking-attributable neurological health loss: age-specific burden and health disparities.
   J Neurol Neurosurg Psychiatry. 2025;96:937-946.
   PubMed     Abstract available
   
   
   
3. MAGILL N, Tank R, Ferguson D, Alston D, et al
   Accelerated long-term forgetting as a predictor of clinical onset in presymptomatic autosomal dominant Alzheimer's disease.
   J Neurol Neurosurg Psychiatry. 2025 Sep 9:jnnp-2025-336750.
   PubMed     Abstract available
   
   
   August 2025
4. DE GIORGI R, Ghenciulescu A, Yotter C, Taquet M, et al
   Glucagon-like peptide-1 receptor agonists for major neurocognitive disorders.
   J Neurol Neurosurg Psychiatry. 2025;96:870-883.
   PubMed     Abstract available
   
   
   July 2025
5. AHN J, Lee EH, Yoo H, Shin D, et al
   Tailoring thresholds for interpreting plasma p-tau217 levels.
   J Neurol Neurosurg Psychiatry. 2025;96:722-727.
   PubMed     Abstract available
   
   
   June 2025
6. BARBA L, Bellomo G, Alcolea D, Wojdala AL, et al
   Serum level changes of the synaptic marker beta-synuclein in Alzheimer's disease continuum and other dementias.
   J Neurol Neurosurg Psychiatry. 2025 Jun 26:jnnp-2025-336189.
   PubMed     Abstract available
   
   
   May 2025
7. LUNN MP
   Biomarker-based Alzheimer's diagnosis: learning to use p-tau217 wisely.
   J Neurol Neurosurg Psychiatry. 2025 May 24:jnnp-2025-336572.
   PubMed    
   
   
   December 2024
8. HAZAN J, Abel E, Rosa Grilo M, Alawode D, et al
   How well do plasma Alzheimer's disease biomarkers reflect the CSF amyloid status?
   J Neurol Neurosurg Psychiatry. 2024 Dec 18:jnnp-2024-334122.
   PubMed     Abstract available
   
   
   
9. JUNG JH, Byun MS, Yi D, Ahn H, et al
   Telomere length, in vivo Alzheimer's disease pathologies and cognitive decline in older adults.
   J Neurol Neurosurg Psychiatry. 2024 Dec 12:jnnp-2024-334314.
   PubMed     Abstract available
   
   
   November 2024
10. FRISONI GB
    Pathophysiology, diagnosis and care of Alzheimer's disease are coming together.
    J Neurol Neurosurg Psychiatry. 2024 Nov 12:jnnp-2024-333864.
    PubMed    
    
    
    October 2024
11. AGHAMOOSA S, Lopez J, Rbeiz K, Fleischmann HH, et al
    A phase I trial of accelerated intermittent theta burst rTMS for amnestic MCI.
    J Neurol Neurosurg Psychiatry. 2024;95:1036-1045.
    PubMed     Abstract available
    
    
    
12. LEHMANN S, Schraen-Maschke S, Vidal JS, Delaby C, et al
    Clinical value of plasma ALZpath pTau217 immunoassay for assessing mild cognitive impairment.
    J Neurol Neurosurg Psychiatry. 2024;95:1046-1053.
    PubMed     Abstract available
    
    
    September 2024
13. RABL M, Clark C, Dayon L, Popp J, et al
    Neuropsychiatric symptoms in cognitive decline and Alzheimer's disease: biomarker discovery using plasma proteomics.
    J Neurol Neurosurg Psychiatry. 2024 Sep 17:jnnp-2024-333819.
    PubMed     Abstract available
    
    
    July 2024
14. MATSUOKA T, Oya N, Narumoto J, Kitani-Morii F, et al
    Reduced pineal volume may be associated with amyloid pathology and not with putative Lewy body pathology.
    J Neurol Neurosurg Psychiatry. 2024;95:791-792.
    PubMed    
    
    
    June 2024
15. DOBSON R, Patterson K, Malik R, Mandal U, et al
    Eligibility for antiamyloid treatment: preparing for disease-modifying therapies for Alzheimer's disease.
    J Neurol Neurosurg Psychiatry. 2024 Jun 11:jnnp-2024-333468.
    PubMed     Abstract available
    
    
    
16. UNDERWOOD BR
    Predicting how many people might receive treatment with new therapies for Alzheimer's disease.
    J Neurol Neurosurg Psychiatry. 2024 Jun 11:jnnp-2024-333941.
    PubMed    
    
    
    April 2024
17. KOROLOGOU-LINDEN R, Xu B, Coulthard E, Walton E, et al
    Genetics impact risk of Alzheimer's disease through mechanisms modulating structural brain morphology in late life.
    J Neurol Neurosurg Psychiatry. 2024 Apr 25:jnnp-2023-332969.
    PubMed     Abstract available
    
    
    March 2024
18. SHIR D, Corriveau-Lecavalier N, Bermudez Noguera C, Barnard L, et al
    Clinicoradiological and neuropathological evaluation of primary progressive aphasia.
    J Neurol Neurosurg Psychiatry. 2024 Mar 21:jnnp-2023-332862.
    PubMed     Abstract available
    
    
    
19. ANDERSON EL, Davies NM, Korologou-Linden R, Kivimaki M, et al
    Dementia prevention: the Mendelian randomisation perspective.
    J Neurol Neurosurg Psychiatry. 2024;95:384-390.
    PubMed     Abstract available
    
    
    January 2024
20. PATEL V, Edison P
    Cardiometabolic risk factors and neurodegeneration: a review of the mechanisms underlying diabetes, obesity and hypertension in Alzheimer's disease.
    J Neurol Neurosurg Psychiatry. 2024 Jan 30:jnnp-2023-332661.
    PubMed     Abstract available
    
    
    
21. KEUSS SE, Coath W, Cash DM, Barnes J, et al
    Rates of cortical thinning in Alzheimer's disease signature regions associate with vascular burden but not with beta-amyloid status in cognitively normal adults at age 70.
    J Neurol Neurosurg Psychiatry. 2024 Jan 10:jnnp-2023-332067.
    PubMed     Abstract available
    
    
    December 2023
22. YANG T, Xiao Y, Cheng Y, Huang J, et al
    Epigenetic clocks in neurodegenerative diseases: a systematic review.
    J Neurol Neurosurg Psychiatry. 2023;94:1064-1070.
    PubMed     Abstract available
    
    
    November 2023
23. GOLDBERG TE, Lee S, Devanand DP, Schneider LS, et al
    Comparison of relative change with effect size metrics in Alzheimer's disease clinical trials.
    J Neurol Neurosurg Psychiatry. 2023 Nov 18:jnnp-2023-331941.
    PubMed     Abstract available
    
    
    October 2023
24. GRAHAM N, Zimmerman K, Heslegrave AJ, Keshavan A, et al
    Alzheimer's disease marker phospho-tau181 is not elevated in the first year after moderate-to-severe TBI.
    J Neurol Neurosurg Psychiatry. 2023 Oct 13:jnnp-2023-331854.
    PubMed     Abstract available
    
    
    
25. LI H, Tan CC, Tan L, Xu W, et al
    Predictors of cognitive deterioration in subjective cognitive decline: evidence from longitudinal studies and implications for SCD-plus criteria.
    J Neurol Neurosurg Psychiatry. 2023;94:844-854.
    PubMed     Abstract available
    
    
    September 2023
26. SHINOHARA M, Gheni G, Hitomi J, Bu G, et al
    APOE genotypes modify the obesity paradox in dementia.
    J Neurol Neurosurg Psychiatry. 2023;94:670-680.
    PubMed     Abstract available
    
    
    
27. DUNNE R, Coulthard E
    Tipping the scales towards routine APOE genotyping.
    J Neurol Neurosurg Psychiatry. 2023;94:669.
    PubMed    
    
    
    August 2023
28. CHUN MY, Jang H, Kim SJ, Park YH, et al
    Emerging role of vascular burden in AT(N) classification in individuals with Alzheimer's and concomitant cerebrovascular burdens.
    J Neurol Neurosurg Psychiatry. 2023 Aug 9:jnnp-2023-331603.
    PubMed     Abstract available
    
    
    June 2023
29. SU WM, Gu XJ, Dou M, Duan QQ, et al
    Systematic druggable genome-wide Mendelian randomisation identifies therapeutic targets for Alzheimer's disease.
    J Neurol Neurosurg Psychiatry. 2023 Jun 22:jnnp-2023-331142.
    PubMed     Abstract available
    
    
    
30. COULTHARD E, Hosseini AA
    Blood biomarkers: ready for clinical practice?
    J Neurol Neurosurg Psychiatry. 2023;94:409-410.
    PubMed    
    
    
    
31. LEHMANN S, Schraen-Maschke S, Vidal JS, Delaby C, et al
    Plasma phosphorylated tau 181 predicts amyloid status and conversion to dementia stage dependent on renal function.
    J Neurol Neurosurg Psychiatry. 2023;94:411-419.
    PubMed     Abstract available
    
    
    April 2023
32. DAI L, Gao F, Wang Q, Lv X, et al
    Molecules of senescent glial cells differentiate Alzheimer's disease from ageing.
    J Neurol Neurosurg Psychiatry. 2023 Apr 3:jnnp-2022-330743.
    PubMed     Abstract available
    
    
    
33. ALTOMARE D, Stampacchia S, Ribaldi F, Tomczyk S, et al
    Plasma biomarkers for Alzheimer's disease: a field-test in a memory clinic.
    J Neurol Neurosurg Psychiatry. 2023 Apr 3:jnnp-2022-330619.
    PubMed     Abstract available
    
    
    
34. VACCHIANO V, Mastrangelo A, Zenesini C, Baiardi S, et al
    Elevated plasma p-tau181 levels unrelated to Alzheimer's disease pathology in amyotrophic lateral sclerosis.
    J Neurol Neurosurg Psychiatry. 2023 Apr 3:jnnp-2022-330709.
    PubMed     Abstract available
    
    
    
35. VAN 'T HOOFT JJ, Pelkmans W, Tomassen J, Smits C, et al
    Distinct disease mechanisms may underlie cognitive decline related to hearing loss in different age groups.
    J Neurol Neurosurg Psychiatry. 2023;94:314-320.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge.